Strike a Blow Against Depression with Worldwide’s Clinical Trial and Research Expertise

According to the World Health Organization (WHO), more than 300 million people worldwide suffer from depression.[i] It is a major contributor to the overall global burden of disease, yet it is also a condition that is both often misdiagnosed and so burdened with stigma that many sufferers avoid seeking treatment.

For researchers working to alleviate the debilitating burden of depression, these and other factors can complicate the testing of promising therapies. You need the expertise of a clinical research organization with access to resources that can help you source and screen suitable trial participants and who are knowledgeable in the dynamics and burden of depression.

With 30+ years of experience supporting CNS and psychiatric research, Worldwide is an internationally acclaimed expert in the area of clinical trial management. We offer full-service Phase I-Phase IV and real-world evidence clinical research services for studies focused on the treatment of depression and other mental health conditions. Our teams are familiar with relevant assessment batteries, diagnostic tools, and a wide range of commercial and proprietary rater response systems. Our clinical trial data experts are second to none at creating and managing an infrastructure for capturing, consolidating, and validating clinical trial data so that you can gain the insights you need to bring your product to its next stage as quickly as possible.

[i] http://www.who.int/en/news-room/fact-sheets/detail/depression

 

.